Polypeptide And DNA Immunization Against Coccidioides Spp. Infections
Researchers at the University of California, San Diego have patented the use of novel Coccidioides-specific antigens, polypeptides, and the nucleotide sequences that encode them as immunogenic antigens for a preventative or therapeutic vaccine for coccidioidomycosis, or for detection of immune responses in individuals infected by Coccidioides spp (e.g. C. posadasii or C. immitis).
Patent Number: US7262027B2
Application Number: US2004794287A
Inventor: Cole, Garry T. | Yu, Jieh Juen | Xue, Jianmin | Hung, Chiung Yu | Seshan, Kalpathi R. | Kirkland, III, Theo N.
Priority Date: 14 Mar 2003
Priority Number: US7262027B2
Application Date: 3 Mar 2004
Publication Date: 28 Aug 2007
IPC Current: C12P002106 | C07H002102 | C07H002104 | C07K001437 | A61K003900
US Class: 4350691 | 4352523 | 4352541 | 43525411 | 4353201 | 5360237 | 5360241 | 5360242
Assignee Applicant: Medical College of Ohio,Toledo | The Regents of the University of California | United States of America Represented by the Department of Veterans Affairsshington
Title: Polypeptide and DNA immunization against Coccidioides spp. infections
Usefulness: Polypeptide and DNA immunization against Coccidioides spp. infections
Summary: The composition and methods are useful for generating an immunological response in an individual, or for diagnosing, preventing or treating Coccidioides spp. infection and diseases states associated with the infection.
Novelty: New isolated nucleic acid molecules and polypeptides for generating an immune response in an individual, or for diagnosing, preventing or treating Coccidioides spp. infection and diseases states associated with the infection
生物醫學
病原
Intellectual Property Info Tech ID/UC Case 22460/2003-F16-0 Related Cases 2003-F16-0
美國
